Gene · 9211
Papers3,019
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,019
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptomic Studies of Antidepressant Action in Rodent Models of Depression: A First Meta-Analysis. | Int J Mol Sci | 2022 | 36362329 | PubTator, text mining | PubMed |
| Anti-leucine-rich glioma-inactivated 1 encephalitis: two case reports and a review of the literature. | J Med Case Rep | 2022 | 36348436 | PubTator, text mining | PubMed |
| Anti-contactin-associated protein-like 2 antibody-associated encephalitis in children: A case report and literature review. | Front Pediatr | 2022 | 36340710 | PubTator, text mining | PubMed |
| The role of contactin-associated protein-like 2 in neurodevelopmental disease and human cerebral cortex evolution. | Front Mol Neurosci | 2022 | 36340692 | PubTator, text mining | PubMed |
| Autoimmune encephalitis with posterior reversible encephalopathy syndrome: A case report. | World J Clin Cases | 2022 | 36338200 | PubTator, text mining | PubMed |
| Acute cerebral infarction of posterior circulation in a patient with vertebral artery fenestration deformity: A case report. | Heliyon | 2022 | 36325143 | PubTator, text mining | PubMed |
| Leucine-rich glioma-inactivated 1 antibody encephalitis as a rare cause of delirium. | Geriatr Gerontol Int | 2022 | 36321771 | PubTator, text mining | PubMed |
| A Chinese female patient with LGI1 and mGluR5 antibodies: A case report. | Medicine (Baltimore) | 2022 | 36316880 | PubTator, text mining | PubMed |
| Anti-Leucine-rich glioma-inactivated Protein 1 antibody-associated encephalitis complicated by minimal change nephrotic syndrome: a case report. | Eur Rev Med Pharmacol Sci | 2022 | 36314326 | PubTator, text mining | PubMed |
| Presence of anti-nuclear antibody associated with worse clinical outcomes of anti-NMDAR encephalitis. | Front Neurol | 2022 | 36313496 | PubTator, text mining | PubMed |
| Autoimmune diseases and cancers overlapping with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic review. | Mult Scler J Exp Transl Clin | 2022 | 36311694 | PubTator, text mining | PubMed |
| Characterization of cardiac bradyarrhythmia associated with LGI1-IgG autoimmune encephalitis. | Front Immunol | 2022 | 36304459 | PubTator, text mining | PubMed |
| Altered Extracellular Matrix as an Alternative Risk Factor for Epileptogenicity in Brain Tumors. | Biomedicines | 2022 | 36289737 | PubTator, text mining | PubMed |
| Targeting RTN4/NoGo-Receptor reduces levels of ALS protein ataxin-2. | Cell Rep | 2022 | 36288715 | PubTator, text mining | PubMed |
| Delayed encephalopathy after COVID-19: A case series of six patients. | Medicine (Baltimore) | 2022 | 36281140 | PubTator, text mining | PubMed |
| Anti-LGI1-Associated Myopathy in the Setting of Neuromuscular Hyperexcitability Syndrome. | JAMA Neurol | 2022 | 36279120 | PubTator, text mining | PubMed |
| Autoimmune antibodies in first-episode psychosis with red flags: A hospital-based case-control study protocol. | Front Psychiatry | 2022 | 36276313 | PubTator, text mining | PubMed |
| Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies. | J Neuroinflammation | 2022 | 36273158 | PubTator, text mining | PubMed |
| Seizure Semiology in Antibody-Associated Autoimmune Encephalitis. | Neurol Neuroimmunol Neuroinflamm | 2022 | 36266054 | PubTator, text mining | PubMed |
| Increased T- and B-cells associated with the phenotype of autoimmune limbic encephalitis with mainly memory dysfunction. | J Transl Autoimmun | 2022 | 36247087 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9211/papers?page=42